Home Newsfeeds Orchard Therapeutics Q2 EPS $(0.04) Up From $(0.29) YoY

Orchard Therapeutics Q2 EPS $(0.04) Up From $(0.29) YoY

Orchard Therapeutics (NASDAQ:ORTX) reported quarterly losses of $(0.04) per share. This is a 86.21 percent increase over losses of $(0.29) per share from the same period last year.

byBenzinga Newsdesk

August 4, 2022

1 minute read

Orchard Therapeutics (NASDAQ:ORTX) reported quarterly losses of $(0.04) per share. This is a 86.21 percent increase over losses of $(0.29) per share from the same period last year.

Mike Pence Would Get Rid Of Jerome Powell If Elected President: ‘We Need Fresh Leadership At The Fed’

By Chris Katje

September 27, 2:54 PM

A Republican candidate in the 2024 presidential race has been criticizing the Federal Reserve and Chairman Jerome Powell, suggesting that the recent actions of the Fed and the potential replacement of Powell could emerge as key topics in the 2024 election discourse.

FOX

Lottery.com Inc. Announces Successful Fundraising And Acquisition Update, Setting The Stage To Fully Resume Operations; Company Will Proceed With The Acquisition Of Nook Holdings To Further Develop Its Sports.com Brand In The Middle East

By Benzinga Newsdesk

December 18, 2:04 PM

Lottery.com Inc. (NASDAQ:LTRY, LTRYW)))) ("Lottery.com" or the "Company"), a leading technology company that is transforming how, where, and when the lottery is played, is pleased to announce additional new funding. This

LTRY